Halofuginol derivatives and their use in cosmetic and pharmaceutical compositions
US10155742B2 · kind B2 · utility
1Cited by
24References
15Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 11, 2013 |
| Grant date | Dec 18, 2018 |
| Priority date | — |
| Expiry date | Apr 20, 2033 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides halofuginol, and derivatives and salts thereof, including diasteromerically enriched compositions thereof. The invention also provides pharmaceutical and cosmetic compositions thereof as well as methods for using halofuginol and derivatives thereof in treating chronic inflammatory diseases, autoimmune diseases, dry eye syndrome, fibrosis, scar formation, angiogenesis, viral infections, malaria, ischemic damage, transplant rejection, neurodegenerative diseases, T-cell neoplasms, and cosmetic conditions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.